Variant report
Variant | nsv584341 |
---|---|
Chromosome Location | chr2:212772101-212774540 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:212770483..212772288-chr2:212787078..212789337,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs530006881 | chr2:212772139-212772140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73073366 | chr2:212772171-212772172 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs73073370 | chr2:212772221-212772222 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs201226873 | chr2:212772226-212772227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530917830 | chr2:212772259-212772260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192081970 | chr2:212772282-212772283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562139970 | chr2:212772358-212772359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73073372 | chr2:212772374-212772375 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs377569041 | chr2:212772431-212772432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs150100134 | chr2:212772512-212772513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73077349 | chr2:212772517-212772518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536972399 | chr2:212772522-212772523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554304657 | chr2:212772566-212772567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs374832475 | chr2:212772567-212772568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546865606 | chr2:212772587-212772588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10187387 | chr2:212772588-212772589 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs200675935 | chr2:212772589-212772590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs138639820 | chr2:212772590-212772591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559136658 | chr2:212772615-212772616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540222858 | chr2:212772637-212772638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs375195329 | chr2:212772643-212772644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529711389 | chr2:212772686-212772687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs575819558 | chr2:212772728-212772729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs79323300 | chr2:212772760-212772761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112792994 | chr2:212772769-212772770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs56232132 | chr2:212772780-212772781 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs149313335 | chr2:212772860-212772861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540555081 | chr2:212772895-212772896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs146274579 | chr2:212772951-212772952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139277158 | chr2:212773003-212773004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184626443 | chr2:212773038-212773039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562201284 | chr2:212773056-212773057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189323199 | chr2:212773069-212773070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs116446379 | chr2:212773096-212773097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181944537 | chr2:212773116-212773117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530308793 | chr2:212773224-212773225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115891916 | chr2:212773273-212773274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs76699225 | chr2:212773305-212773306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs539196988 | chr2:212773342-212773343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566565194 | chr2:212773385-212773386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs375122099 | chr2:212773442-212773443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs114630898 | chr2:212773458-212773459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs569347166 | chr2:212773486-212773487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs184100061 | chr2:212773520-212773521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs73077351 | chr2:212773542-212773543 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs574804490 | chr2:212773601-212773602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533840698 | chr2:212773617-212773618 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554074420 | chr2:212773627-212773628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs577070237 | chr2:212773629-212773630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs35919515 | chr2:212773671-212773672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Schizophrenia | 20838587 | CNVD |
Breast cancer | 17661082 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 18990708 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:212771600-212772200 | Enhancers | Brain Cingulate Gyrus | brain |
2 | chr2:212772000-212772600 | Enhancers | Fetal Heart | heart |
3 | chr2:212772600-212774200 | Weak transcription | Fetal Heart | heart |
4 | chr2:212774200-212774400 | Enhancers | Fetal Heart | heart |